Cartesian Therapeutics shares are trading higher after the company announced that enrollment is progressing in their Phase 3 AURORA trial for Descartes-08 in myasthenia gravis.

Acurx Pharmaceuticals shares are trading higher after the announcement of new clinical trials for ibezapolstat, aimed at treating and preventing recurrent C. difficile infections.

enGene Holdings Inc. shares are trading lower after the company reported a net loss of $29.8 million in Q1 2026, driven by increased operating expenses.

Creative Media & Community Trust Corporation shares are trading lower after the company reported a net loss attributable to common stockholders of $17.7 million for Q4 2025, amid increased impairment of real estate and rising interest expenses.

Editas Medicine shares are trading higher after the company reported significant advancements in its lead candidate, EDIT-401, with a reduction in mean LDL cholesterol levels by over 90% in preclinical studies. The company maintains a strong cash position, ensuring running costs are covered until the third quarter of 2027, and anticipates submitting an IND/CTA by mid-2026 for upcoming human trials.

Syntec Optics shares are trading higher after securing $4 million in defense orders across diversified U.S. military platforms. The new orders reinforce the company's key supplier position in high-profile defense initiatives.

Korro Bio shares are trading higher after the company announced an oversubscribed $85 million private placement to support multiple RNA editing programs.

Dianthus Therapeutics shares are trading higher after the company announced an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy, achieving a crucial milestone that could significantly enhance its position in the autoimmune therapy market.

AN2 Therapeutics shares are trading higher after the company announced a securities purchase agreement for a private placement expected to result in $40 million gross proceeds.

Relmada Therapeutics shares are trading higher after the company announced the completion of an oversubscribed $160 million private placement financing. This move is expected to support continued development of its oncology therapies.

Xenon shares are trading higher after the company announced it will release topline results from the Phase 3 X-TOLE2 study of azetukalner for focal onset seizures.

Socket Mobile shares are trading higher after the company announced industrial scanning solutions compatible with the new iPhone 17e.

Tevogen shares are trading higher after signing a Letter of Intent to evaluate a potential acquisition of Apozeal Pharmaceutical.

Mammoth Energy Services shares are trading lower after the company reported a net loss from continuing operations for the fourth quarter of 2025, which was worse than the previous year, reflecting ongoing operational challenges and a decline in revenue.

Methode Electronics shares are trading lower after the company reported a net loss of $15.9 million in its fiscal third quarter due to industry-wide disruptions in its Automotive segment and challenges in Mexico operations.

Mobix Labs shares are trading higher after the company announced new purchase orders from Gulfstream, reflecting ongoing integration of its high-reliability components in aircraft systems.

Cango Inc. shares are trading higher after the company announced its strategic transformation plan, showcasing increased Bitcoin production and operational optimizations to enhance financial resilience and AI infrastructure.

Solid Biosciences shares are trading higher after announcing an oversubscribed $240 million private placement to fund its development programs.

Genesco Inc. shares are trading higher after the company reported robust Q4 performance with a 7% increase in net sales, driven by significant growth at Journeys and Schuh. The firm also pointed to strong fiscal year 2026 results with a 5% increase in net sales, boosted by positive comparable sales and effective cost management strategies.

OptimizeRx shares are trading higher after the company reported strong Q4 2025 financial results, achieving record net income and adjusted EBITDA, and announcing a $10 million share repurchase program.